- Home
- IMVT vs LNC Comparison
IMVT vs LNC Comparison
Compare IMVT & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMVT | LNC |
|---|---|---|
| Founded | 2018 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.0B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IMVT | LNC |
|---|---|---|
| Price | $40.20 | $43.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 16 |
| Target Price | $33.00 | ★ $43.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $18,212,000,000.00 |
| Revenue This Year | N/A | $9.60 |
| Revenue Next Year | N/A | $3.73 |
| P/E Ratio | ★ N/A | $7.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.58 | $32.18 |
| 52 Week High | $45.42 | $47.67 |
Technical Indicators
Market Signals| Indicator | IMVT | LNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 49.43 |
| Support Level | $37.16 | $41.93 |
| Resistance Level | $41.22 | $46.95 |
| Average True Range (ATR) | 1.39 | 1.12 |
| MACD | -0.36 | -0.33 |
| Stochastic Oscillator | 0.74 | 29.04 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
About LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.